Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Widdowson

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPDZehong Wan, Dramane I Laine, Hongxing Yan, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2011
Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituentJeffrey K Kerns, Hong Nie, William Bondinell, et al.
Journal of Medicinal Chemistry|March 26, 2009
Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Brent McCleland, Sonia Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Discovery of potent and orally bioavailable N,N'-diarylurea antagonists for the CXCR2 chemokine receptorQi Jin, Hong Nie, Brent W McCleland, et al.
The Journal of Biological Chemistry|September 2, 2000
Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migrationJ R White, J M Lee, K Dede, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2007
3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonistsYonghui Wang, Jakob Busch-Petersen, Feng Wang, et al.
Med (New York, N.Y.)|November 13, 2024
No association between the early-life gut microbiota and childhood body mass index and body compositionChristina Egeø Poulsen, Rebecca Vinding, Morten A Rasmussen, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2012
Tyrosine urea muscarinic acetylcholine receptor antagonists: achiral quaternary ammonium groupsQi Jin, Roderick S Davis, Ann M Bullion, et al.
Journal of Medicinal Chemistry|March 5, 2004
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptorKatherine L Widdowson, John D Elliott, Daniel F Veber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbitPatricia L Podolin, Brian J Bolognese, James J Foley, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPDZehong Wan, Dramane I Laine, Hongxing Yan, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2011
Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituentJeffrey K Kerns, Hong Nie, William Bondinell, et al.
Journal of Medicinal Chemistry|March 26, 2009
Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Brent McCleland, Sonia Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Discovery of potent and orally bioavailable N,N'-diarylurea antagonists for the CXCR2 chemokine receptorQi Jin, Hong Nie, Brent W McCleland, et al.
The Journal of Biological Chemistry|September 2, 2000
Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migrationJ R White, J M Lee, K Dede, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2007
3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonistsYonghui Wang, Jakob Busch-Petersen, Feng Wang, et al.
Med (New York, N.Y.)|November 13, 2024
No association between the early-life gut microbiota and childhood body mass index and body compositionChristina Egeø Poulsen, Rebecca Vinding, Morten A Rasmussen, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2012
Tyrosine urea muscarinic acetylcholine receptor antagonists: achiral quaternary ammonium groupsQi Jin, Roderick S Davis, Ann M Bullion, et al.
Journal of Medicinal Chemistry|March 5, 2004
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptorKatherine L Widdowson, John D Elliott, Daniel F Veber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbitPatricia L Podolin, Brian J Bolognese, James J Foley, et al.
Pageof 3